Grant: Planning Grants: Priority Announcement - Reproductive and Child Health
University of British Columbia
$25,000.00
Collaborating to Improve Evidence-based Decision Making for Pediatric Therapeutics
EF 2012-13
Résumé
Lack of research, poor research, and poorly reported research are violations of childrens human rights, declared Dr. Richard Horton, editor in chief, The Lancet in a presentation to the audience of a recent conference on Standards for Research in Child Health. Everyday decisions about how to treat children are dependent upon studies of therapies, and yet there is an astounding lack of good studies upon which to base most treatment decisions. Seventy percent of drugs used to treat children, and ninety percent used in babies, have not been studied properly. It is difficult doing treatment studies in children because many conditions affecting children occur at much lower frequencies than in adults. Studies need to include many centers in order to have enough patients to make good conclusions about the effectiveness of a new therapy. And, there is often a need to follow children for a longer period of time, to make sure a therapy is safe and does not affect their growth or development. At home and abroad, numerous forces are at play to correct past wrongs and generate better therapies for children. Canada, with our high quality health care system and collaborative child health care community, has the potential to be the international leader in determining safe and cost effective treatments for children. There is good experience doing pediatric therapy studies. In the past five years, around four hundred studies were led by Canadian investigators and sponsored by their institution, but much of this activity is fragmented and poorly supported. Currently, there are a number of initiatives in Canada, and involving Canadians internationally, that aim to improve the design, conduct and reporting of pediatric studies in general, and determine how to integrate high priority needs of the health system. Our goal is to bring people involved in these many initiatives together, to determine if there is an interest to coordinate, and leverage activities, across the country.
Programme
Planning Grants: Priority Announcement - Reproductive and Child Health
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
273146
Name
Junker Anne K
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Planning Grants
Projecttitle
Collaborating to Improve Evidence-based Decision Making for Pediatric Therapeutics
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
Planning Grants: Priority Announcement - Reproductive and Child Health
Keyworddelim
Knowledge Exchange
Abstract
Lack of research, poor research, and poorly reported research are violations of childrens human rights, declared Dr. Richard Horton, editor in chief, The Lancet in a presentation to the audience of a recent conference on Standards for Research in Child Health. Everyday decisions about how to treat children are dependent upon studies of therapies, and yet there is an astounding lack of good studies upon which to base most treatment decisions. Seventy percent of drugs used to treat children, and ninety percent used in babies, have not been studied properly. It is difficult doing treatment studies in children because many conditions affecting children occur at much lower frequencies than in adults. Studies need to include many centers in order to have enough patients to make good conclusions about the effectiveness of a new therapy. And, there is often a need to follow children for a longer period of time, to make sure a therapy is safe and does not affect their growth or development. At home and abroad, numerous forces are at play to correct past wrongs and generate better therapies for children. Canada, with our high quality health care system and collaborative child health care community, has the potential to be the international leader in determining safe and cost effective treatments for children. There is good experience doing pediatric therapy studies. In the past five years, around four hundred studies were led by Canadian investigators and sponsored by their institution, but much of this activity is fragmented and poorly supported. Currently, there are a number of initiatives in Canada, and involving Canadians internationally, that aim to improve the design, conduct and reporting of pediatric studies in general, and determine how to integrate high priority needs of the health system. Our goal is to bring people involved in these many initiatives together, to determine if there is an interest to coordinate, and leverage activities, across the country.
Competitiondate
201210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Junker, Anne K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $25,000~ $0~